Finance

Lists
Why is 603259 down 6.60%?
Dive Deeper
603259:SHA
WuXi AppTec Co Ltd
CN¥ 144.30
-6.60%
(-10.20) 1D
10-р сарын 16, 15:00:01 (GMT+8)  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603259...
Open
CN¥ 156.94
High
CN¥ 159.92
Low
CN¥ 139.05
Mkt. cap
484.94Т
Avg. vol.
34.02 сая
Volume
83.61 сая
Dividend
1.45%
Quarterly dividend
CN¥ 0.52
Ex-dividend date
2026 оны 9-р сарын 4
P/E ratio
19.63
52-wk high
CN¥ 173.60
52-wk low
CN¥ 87.09
EPS
CN¥ 7.35
Shares outstanding
1.05 тэрбум
No. of employees
36 мян
Open
CN¥ 156.94
High
CN¥ 159.92
Low
CN¥ 139.05
Mkt. cap
484.94Т
Avg. vol.
34.02 сая
Volume
83.61 сая
Dividend
1.45%
Quarterly dividend
CN¥ 0.52
Ex-dividend date
2026 оны 9-р сарын 4
P/E ratio
19.63
52-wk high
CN¥ 173.60
52-wk low
CN¥ 87.09
EPS
CN¥ 7.35
Shares outstanding
1.05 тэрбум
No. of employees
36 мян
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
2 өдрийн өмнө
Huaxi Securities maintains Buy for WuXi AppTec stock
Profile
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe. Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
About WuXi AppTec Co Ltd
CEOSteve Yang | Ge Li
Employees35.6 мян
Founded2000 оны 12-р сарын 1
Headquarters-
SectorHealth care
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
12.04 тэрбум
10.97 тэрбум
12.44 тэрбум
16.46 тэрбум
Cost of goods sold
6.07 тэрбум
4.91 тэрбум
6.17 тэрбум
-
Cost of revenue
6.07 тэрбум
4.91 тэрбум
6.17 тэрбум
-
Research and development expenses
311.73 сая
236.94 сая
266.96 сая
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
854.49 сая
853.67 сая
891.80 сая
-
Operating expense
1.38 тэрбум
1.26 тэрбум
1.22 тэрбум
-
Total operating expenses
7.45 тэрбум
6.17 тэрбум
7.39 тэрбум
-
Operating income
4.59 тэрбум
4.80 тэрбум
5.04 тэрбум
-
Other non operating income
-470.36 сая
281.37 сая
-266.37 сая
-
EBT including unusual items
5.13 тэрбум
6.75 тэрбум
5.61 тэрбум
-
EBT excluding unusual items
5.11 тэрбум
6.95 тэрбум
5.19 тэрбум
-
Income tax expense
1.55 тэрбум
1.09 тэрбум
936.77 сая
-
Effective tax rate
30.19%
16.12%
16.71%
-
Other operating expenses
57.96 сая
25.84 сая
726.05 мян
-
Net income
3.51 тэрбум
7.08 тэрбум
4.65 тэрбум
-
Net profit margin
29.18%
64.49%
37.40%
-
Earnings per share
1.24
1.42
1.57
2.20
Interest and investment income
1.21 тэрбум
1.87 тэрбум
439.82 сая
-
Interest expense
-226.71 сая
-
-30.95 сая
-
Net interest expenses
981.72 сая
1.87 тэрбум
408.87 сая
-
Depreciation and amortization charges
-
-
-
-
EBITDA
5.21 тэрбум
5.61 тэрбум
5.85 тэрбум
-
Gain or loss from assets sale
-158.03 сая
218.40 сая
-
-
AI content may include mistakes. Learn more
Google аппс